- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
EVALUATION THE LEVEL OF SEROTONIN AND THE ACTIVITY OF ACETYLCHOLINE ESTERASE IN SERA OF SOMEFEMALE WITH TYPE I DIABETES | ||
| Journal of University of Anbar for Pure Science | ||
| Article 33, Volume 7, Issue 1, 2013, Pages 135-144 PDF (640.54 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.37652/juaps.2013.83035 | ||
| Authors | ||
| Ammar G.Kuhait1; Perry H. Saif2; khalid W.Hammod1 | ||
| 1University of Anbar - College of Education for Pure Sciences | ||
| 2Baghdad University - College of Education for Women | ||
| Abstract | ||
| This research included the study of the level of serotonin concentration and the activity of Acetylcholine esterase and their relationship with diabetes type I compared with healthy people (control group). Some other biological variations has been studied accompanying such as the concentration of glucose, cholesterol, triglyceride, HDL,LDL,VLDL in women with type I diabetes compared to healthy..Blood samples have been taken from to women with type I diabetes (IDDM) who are diagnosed by doctors, specialists, ages ranged between 17-37 years. Included in the study (60) model of the blood serum of women with type I diabetes as well as the control group, which included (40) model of the blood serum of healthy women.The study showed a significant increase in the activity of Acetylcholine esterase and the not significant increase in the level of serotonin in women with diabetes type I, as well as a significant increase in the level of concentration of glucose, HbA1C, cholesterol, triglyceride, LDL,VLDL with diabetes compared with control.It also examined the correlation between the level of serotonin andAcetylcholine esterase and Biological Variations of patients with diabetes type I and the control group it was found a positive coloration between the activity of Acetylcholine esterase and the value of the BMI and the level of glucose, HbA1C, the level of triglycerides,andVLDL. While there was anegativecoloration between the level of serotonin, BMI, blood pressure, HDL, and there was a positive coloration between the level of serotonin and the concentration of cholesterol, triglycerides andVLDL | ||
| References | ||
|
1- American Diabetes Association (2007): “Diagnosis and Classification of Diabetes Mellitus”, Diabetes care journal 30: S42 – S47.
2- Le TK, Able SL, Lage MJ (2006). Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression.Cost EffResourAlloc. 4: 18.
3- American Diabetes Association, Inc. (2007): “Diabetes: Magnitude and Mechanisms”, Clinical Diabetes Journal 25: 25 – 28.
4- Shim, M. and England, T. Updated: 5/10/2004. Diabetes mellitus. (cited 2004, may 6), Available from:specialtyLaboratorie.
5- Horseman, N.D. (1996). The physiology of fuel nutrients and pancreatic hormones. In: Essentials of physiology. 2nd edition.Little, Brown and company. Boston P:599-60.
6- Fox, I.S. (2002): Endocrine Glands. In: Human Physiology. 7th ed., McGraw- Hill companies, New York, Chap.11, pp: 299-302.
7- Murray, K.R.; Granner, K. D. and Mayes, A. P., (2000): Pituitary and Hypothalamic Hormones. In: Harper's Biochemistry. 25th ed.., Appleton and Lange, Stamford, Chap.45, pp: 552 – 554.
8- Frazer, A. ;Molinoff, P.B. and Winokur, A. (1994). Biological bases of brain function and disease. Raven press، Ltd، U.S.A. Pp : 47-49.
9- Kandell ER, Schwartz JH, Jessell TM (2000). Principles of Neural Science. 4th ed. New York, USA: McGraw-Hill. pp. 893,896.
10- Cooper JR, Bloom FE, Roth RH (1996). The Biochemical Basis of Neuropharmacology. 7th ed. NewYork, USA: Oxford University Press. pp.352-391.
11-Hardeland R,Pandi-Perumal SR&Cardinali DP, (2006) Melatonin. Int J Biochem Cell Biol, 38, 313-6.
12- Herrera MR, Manjarrez GG, Nishimura ME, Hernandez-RJ (2003). Serotonin-related tryptophan in children with insulin-dependent diabetes. Pediatric Neurol 28:20– 23.
13- Barradas MA, Gill DS, Fonseca VA, Mikhailidis DP, Dandona P (1988). Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest. 18:399–404.
14- Schloss P, Williams DC (1998). The serotonin transporter: a primary target for antidepressant drugs. Biochemistry Department University of Dublin, Trinity College Ireland.J Psychopharmacol. 12.2:115-21.
15- William, F.Ganong, (1999). Review of medical physiology. University of California.Synaptic Transmission pp.92-94.
16- Ragoobirsingh, D & Morrison, E.Y. (1992): “Change in Serum Cholinesterase Activity in Jamaican Diabetes”, Journal of the National Medical Association, VOL. 84, No.10 pp: 853-855.
17- Inacio L.G., Stefanello F, Sausen L.D., Maria M.V., Schetinger M.R. &Goncalves J.F (,2006). “ Serum cholinesterase activity in diabetes and associated pathologies ” Diabetes Res.72(1):28-32.
18- Rose, L.,Davis, D.A.andLehmaan, H., Lancet(1965). pp 225,563.
19- Vandekar, M. (1978). WHO/ VBS/ 78, 692.
20-Harenberg,J,Huhle,G.,Giese Ch., Wang،L., Feuring ،M., Song, X., Hofmann،U.: (2000). Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin induced. thrombocytopenia. british journal of Hematology 109 182-186 Address :Harenbergj.,University of Heidelberg،Germany.
21-American Diabetes Association (2002): “Elevated Serum Concentration of Adipose-Derived Factor, Adiponectin, in Patients With Type 1 Diabetes”, Diabetes care journal V 25: pp 1665-1666.
22- World Health Organization (1999): Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of WHO consultation. Part 1: Diagnosis and classification of diabetes Mellitus. Geneva, World Health Org.
23- Cataline, F. P.; Mallo, F. and Andrade, A. M. (2002): “AHered GH Elimination kinetics in Type 1 Diabetes Mellitus can Explain the Elevation in Circulating Levels: Bicompartmental Approach” J. clin. Endocrinol.Metab., 87 (4): 1785 – 1790.
24- Kareem, I.; Jaweed, S. A. and Bardapurkar, V. P. (2004):“Study of magnesium, Glycosylated hemoglobin and lipid profile in diabetic retinopathy” clin. Biochem., 19 (20): 124 – 127.
25- O’Brien, S.F; Watts, G.G; Powrie, J.K; shaw، K.M; Miller, N.J. (1996). "Lipds lipoproteins antioxidants and glomerulan and tubular dysfunction in type I diabetes". Diabetes. Res. Clin. Pract. 32 (1-2): 81-90.
26- Maechler, P., Wollheim C., Bentzen, C. and Niesors E. (1993). Importance of exogenous cholesterol in diabetic rates: effect of treatment with insulin deficiency or with an Acyl-coA: cholersterol acyl tranceferase-inhibtor. Ann. Nutr. Metab., 37: 199-209.
27-- Maxwell, S; Holm, G; Bondjers, G, Wiklurd, O. (1997). "Comparison of antioxidant in lipoprotein fraction from insulin-dependent diabeties and healthy controls".Atherosclerosis. 129(1): 89-96.
28- Rubins, H.B., Robins, S.J., Collins, D. (2002). Treating Diabetic Dyslipidemia with Gemfibrozil for secondary prevention of coronary Heart Diseaes. Veterans Affairs High-Density Cholesterol Intervention trial study Group. N EnglJ.Med. 341:410-8.
29- Bishop M., Duben – Engel Kirk J.andfody E.(2000) Clinical chemistry 4th ed., Lippincot Williams and Wilkins, Philadelphia, USA., PP. 220 – 221.
30- Magarian EO, Dietz AJ (1 987). Correlation of cholinesterase with serum lipids and lipoproteins.J ClinPharmacol. 27:819-820
31- Osada J, Aykegas H, Cao G, Micro-obradors J, Palacious- Alaiz E (1989). Changes in serum cholinesterase (EC 3.11.88) activity in rats consuming a high-fat diet. Br J Nutr.62:343-348.
32- Cucuianu M, Opincaru A, Tapalaga D (1978). Similar behaviour of lecithin-cholesterol acyltransferase and pseudocholinesterasein liver disease and hyperlipoproteinemia.ClinChimActa85 : 73–79.
33- Malyszko J, Urano T, Knofler R, et al (1994) Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res. 75:569–76.
34- Eriksson E. & Humble M. (1990) Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research., Basel, Karger.
35- Berry WTC, Cowin PJ, Davies DR (1954). A relationship between body fat and plasma pseudo-cholinesterase.Br J Nutr. 8: 79–82.
36- Al-Mutawaa A M J M (2010),The role of calcium ion cholinesterase activity and its correlation with some metal ions in sera with type II Diabetes mellitus،thesis phd،university of basrah.
37- Jafri SM, Chandra N, Dhawan S, Soni D, Chandra M, Shanker K (1992). Factors influencing platelet serotonin uptake in essential hypertension. Int J Cardiol.;34:327–333.
38- Heron D, Sminitzky M, Hershkowitz M (1980). Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. ProcNatlAcadSci USA.77:7463-7. | ||
|
Statistics Article View: 392 PDF Download: 189 |
||